New York, NY, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large Portion of Potential Financial Liability February 06, 2026…
Company announcement no. 7 / 2026 Schindellegi, Switzerland – 6 February 2026 Share-Based Incentive Program 2026 Trifork Group AG (“Trifork”)…
Company announcement No. 11/2025 6 February 2026 Notice to convene the Annual General Meeting 2026 The Annual General Meeting…
February 06, 2026 03:30 ET | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06,…
VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât.…
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT…
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100%…
February 05, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) --…
February 05, 2026 07:00 ET | Source: Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE)…